Funding & Disinvestments
-
Murang’a County deploys Starlink satellite internet in 170 health facilities to enhance rural healthcare
The ambitious project targets approximately 1.2 million residents, most of whom inhabit rural communities where traditional connectivity has remained inconsistent.
-
Jardine Matheson to acquire Australia’s I-MED Radiology Network in US$2.4B healthcare expansion
I-MED operates a network of 215 clinics across Australia and New Zealand and performs more than seven million patient procedures annually.
-
Regeneron strikes US$2.32B partnership with Parabilis to advance next-generation peptide therapies
Under the collaboration, the companies will evaluate Helicons both as standalone therapies and as payloads linked to Regeneron antibodies.
-
Pfizer obtains EC approval for first once-weekly subcutaneous hemophilia treatment
The approval applies to adolescents and adults weighing at least 35 kilograms who have haemophilia A with factor VIII inhibitors or haemophilia B with factor IX inhibitors.
-
M42 partners with Diaverum to launch AI-powered kidney.com platform to boost kidney health awareness
The platform debuted across the UAE, France, Germany, Portugal, and the UK, with additional international rollouts planned in the coming months.
-
Cipla South Africa to supply critical childhood vaccines in new state tender
The pharmaceutical company submitted bids across several critical childhood immunisation categories, including the Pneumococcal Conjugate Vaccine (PCV10), Rotavirus vaccine, and paediatric Hepatitis B vaccine.
-
-
Eli Lilly bets US$2.25B on Profluent’s AI-designed gene editing recombinases
The collaboration focuses on multiple research programmes designed to develop and commercialise site-specific recombinases for diseases characterised by severe unmet medical needs.
-
Gulf healthcare systems shift from importing excellence to building it locally
Governments and private institutions across the GCC are investing unprecedented sums into healthcare infrastructure, recruiting top talent, and acquiring cutting-edge technology.
-
Izz Pharma opens a US$26M IV Solutions plant in Oman to boost drug security
Spread across approximately 20,000 square metres, the plant is equipped with automated production lines and advanced quality control laboratories built to international pharmaceutical standards.